1 Min Read
June 13 (Reuters) - Moleculin Biotech Inc
* Moleculin announces preparation to file an IND with the FDA for WP1220 for treatment of cutaneous T-Cell lymphoma Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.